U.S. COPD Market - Therapeutic Overview and Patient Outlook
U.S. COPD Market - Therapeutic Overview and Patient Outlook
RELEASE DATE
18-Jun-2007
18-Jun-2007
REGION
North America
North America
Research Code: N165-01-00-00-00
SKU: HC02030-NA-MR_07345
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
HC02030-NA-MR_07345
Description
This research service covers the U.S. COPD market from 2003-2013. Included are patient forecasts and a therapeutic overview. The market is segmented by product class: bronchodilators, anti-inflammatories, combination therapies, and novel therapeutic approaches. The novel therapeutic approaches segment covers selected products in the pipeline that are outside current marketed segments. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.
Table of Contents
Executive Summary
- Introduction
Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
Disease Overview
- Introduction
- Disease Definition
- Symptoms
- Risk Factors
- Diagnosis
- Treatments
- Drug Delivery Methods
- Disease Statistics
- Competitive Structure
Patient Outlook
- Patient Forecasts
General Market Trends
- Challenges
- Strategic Recommendations for Challenges
- Market Drivers
- Market Restraints
Decision Support Databases
Popular Topics
This research service covers the U.S. COPD market from 2003-2013. Included are patient forecasts and a therapeutic overview. The market is segmented by product class: bronchodilators, anti-inflammatories, combination therapies, and novel therapeutic approaches. The novel therapeutic approaches segment covers selected products in the pipeline that are outside current marketed segments. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | N165-01-00-00-00 |
Is Prebook | No |